Back
Citizens Financial Services Vs. Sarepta Therapeutics Industry Stock Comparison
Sell
25
CZFS
Citizens Financial Services
Last Price:
$56.13
Seasonality Move:
-0.8%
Sell
46
SRPT
Sarepta Therapeutics
Last Price:
$54.38
Seasonality Move:
15.14%
Sell
25
Citizens Financial Services (CZFS)
is a Sell
Is Citizens Financial Services a Buy, Sell or Hold?
-
The current Citizens Financial Services [CZFS] share price is $54.00. The Score for CZFS is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
-
CZFS is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
46
Sarepta Therapeutics (SRPT)
is a Sell
Is Sarepta Therapeutics a Buy, Sell or Hold?
-
The current Sarepta Therapeutics [SRPT] share price is $54.43. The Score for SRPT is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
-
SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
CZFS Stock Price Chart
What is Citizens Financial Services's stock price today?
-
The Citizens Financial Services share price today is $54.00Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CZFS is experiencing buying pressure, which is a positive indicator for future bullish movement.
SRPT Stock Price Chart
What is Sarepta Therapeutics's stock price today?
-
The Sarepta Therapeutics share price today is $54.43Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.
CZFS Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 14.77 | Buy |
Relative Strength Index (14 RSI): | 37.47 | Sell |
Chaikin Money Flow: | 10210 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | ( - ) | Buy |
Bollinger Bands (100): | ( - ) | Buy |
SRPT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -11.96 | Sell |
Relative Strength Index (14 RSI): | 19.8 | Sell |
Chaikin Money Flow: | -4277485 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (66.24 - 101.14) | Sell |
Bollinger Bands (100): | (90.97 - 127.95) | Sell |
CZFS Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 57.66 | Sell |
20-day SMA: | 57.77 | Sell |
50-day SMA: | 59.91 | Sell |
200-day SMA: | 57.55 | Sell |
8-day EMA: | 54.02 | Sell |
20-day EMA: | 40.18 | Buy |
50-day EMA: | 22.01 | Buy |
200-day EMA: | 6.54 | Buy |
SRPT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.54 | Sell |
20-day SMA: | 78.39 | Sell |
50-day SMA: | 97.73 | Sell |
200-day SMA: | 122.38 | Sell |
8-day EMA: | 63.87 | Sell |
20-day EMA: | 75.73 | Sell |
50-day EMA: | 92.2 | Sell |
200-day EMA: | 113.44 | Sell |
Citizens Financial Services Earnings Growth & CZFS Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.27 per share, an increase next quarter of $0.03 per share, an increase this year of $1.09 per share, and an increase next year of $0.35 per share.
Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates
-
Analysts estimate an earnings increase this quarter of $2.39 per share, a decrease next quarter of $0.51 per share, an increase this year of $5.17 per share, and an increase next year of $5.45 per share.
Citizens Financial Services Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Sarepta Therapeutics Technical Analysis
Mar 24 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | Mar 31 | Apr 1 | Apr 2 | Apr 3 | Apr 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | Apr | |||||||||
24 | 25 | 26 | 27 | 28 | 31 | 01 | 02 | 03 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |